Can antibiotic treatment in preweaning rats alter body composition in adulthood?

Fanny B Morel1, Annemarie Oosting, Hugues Piloquet

  • 1INRA-UMR 1280 Physiologie des adaptations nutritionnelles, Nantes, France.

Neonatology
|February 26, 2013
PubMed

Insights

Early-life antibiotic exposure, specifically amoxicillin, did not program adult body composition or obesity risk in rats. This study found no long-term effects on growth or body weight despite temporary changes in gut microbiota and food intake.

Area of Science:

  • Developmental programming
  • Microbiome research
  • Obesity research

Background:

  • Antibiotic use in infancy is hypothesized to influence adult body composition and obesity risk.
  • This hypothesis is plausible due to antibiotics' impact on the developing intestinal microbiota.
  • The gut microbiota plays a role in fat development and appetite regulation.

Purpose of the Study:

  • To investigate the impact of neonatal amoxicillin treatment on rat growth and body composition.
  • To determine if early-life antibiotic exposure programs adult body composition.

Main Methods:

  • Neonatal rats received amoxicillin or vehicle via oral gavage from postnatal day 5 to 15.
  • Growth, food intake, body composition, and plasma leptin were measured until postnatal day 130.
  • Faecal microbiota composition was analyzed using real-time quantitative polymerase chain reaction.

Main Results:

  • Amoxicillin altered faecal microbiota composition at postnatal day 21, but this effect was not sustained.
  • A transient increase in food intake was observed in amoxicillin-treated rats immediately after weaning.
  • No significant differences in growth or adult body composition were found between groups.

Conclusions:

  • Neonatal amoxicillin treatment in rats does not lead to programming of adult body weight or composition.
  • The study found no evidence supporting a link between early-life wide-spectrum antibiotic exposure and long-term obesity risk in this model.
Abstract